Emerald Advisers Inc. PA decreased its holdings in shares of Acadia Healthcare Company Inc (NASDAQ:ACHC) by 29.2% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 27,709 shares of the company’s stock after selling 11,408 shares during the quarter. Emerald Advisers Inc. PA’s holdings in Acadia Healthcare were worth $975,000 as of its most recent SEC filing.
Several other institutional investors have also added to or reduced their stakes in ACHC. Dimensional Fund Advisors LP grew its holdings in shares of Acadia Healthcare by 27.8% during the second quarter. Dimensional Fund Advisors LP now owns 5,153,977 shares of the company’s stock worth $210,849,000 after buying an additional 1,122,452 shares in the last quarter. Copper Rock Capital Partners LLC purchased a new stake in shares of Acadia Healthcare during the second quarter worth $27,394,000. BlackRock Inc. grew its holdings in shares of Acadia Healthcare by 2.1% during the second quarter. BlackRock Inc. now owns 10,336,713 shares of the company’s stock worth $422,875,000 after buying an additional 210,999 shares in the last quarter. State of New Jersey Common Pension Fund D grew its holdings in shares of Acadia Healthcare by 22.5% during the third quarter. State of New Jersey Common Pension Fund D now owns 980,000 shares of the company’s stock worth $34,496,000 after buying an additional 180,000 shares in the last quarter. Finally, Rothschild Asset Management Inc. grew its holdings in shares of Acadia Healthcare by 21.9% during the second quarter. Rothschild Asset Management Inc. now owns 961,308 shares of the company’s stock worth $39,327,000 after buying an additional 172,568 shares in the last quarter.
Shares of ACHC opened at $44.75 on Friday. The company has a quick ratio of 1.24, a current ratio of 1.24 and a debt-to-equity ratio of 1.20. Acadia Healthcare Company Inc has a 12-month low of $26.92 and a 12-month high of $45.35. The stock has a market capitalization of $3.66 billion, a P/E ratio of 19.46, a PEG ratio of 1.49 and a beta of 0.22.
In related news, Director Reeve B. Waud sold 41,865 shares of the company’s stock in a transaction dated Thursday, November 1st. The shares were sold at an average price of $45.00, for a total value of $1,883,925.00. Following the completion of the sale, the director now owns 14,213 shares of the company’s stock, valued at $639,585. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Corporate insiders own 11.10% of the company’s stock.
ACHC has been the subject of a number of research reports. BidaskClub raised shares of Acadia Healthcare from a “strong sell” rating to a “sell” rating in a report on Saturday, October 6th. Craig Hallum lowered shares of Acadia Healthcare from a “buy” rating to a “hold” rating in a report on Wednesday, October 17th. They noted that the move was a valuation call. Mizuho set a $37.00 target price on shares of Acadia Healthcare and gave the stock a “hold” rating in a report on Tuesday, August 28th. ValuEngine raised shares of Acadia Healthcare from a “strong sell” rating to a “sell” rating in a report on Thursday, October 18th. Finally, Cantor Fitzgerald reaffirmed a “hold” rating and set a $39.00 target price on shares of Acadia Healthcare in a report on Thursday, October 18th. Eight analysts have rated the stock with a hold rating and four have issued a buy rating to the company’s stock. The company presently has an average rating of “Hold” and a consensus price target of $43.11.
About Acadia Healthcare
Acadia Healthcare Company, Inc develops and operates inpatient psychiatric facilities, residential treatment centers, group homes, substance abuse facilities, and outpatient behavioral healthcare facilities to serve the behavioral health and recovery needs of communities. The company operates acute inpatient psychiatric facilities, which offer evaluation and crisis stabilization of patients with severe psychiatric diagnoses; specialty treatment facilities, including residential recovery facilities, eating disorder facilities, and comprehensive treatment centers that provide continuum care for adults with addictive disorders and co-occurring mental disorders; and residential treatment centers, which treat patients with behavioral disorders in a non-hospital setting, including outdoor programs.
Further Reading: How accurate is the Rule of 72?
Want to see what other hedge funds are holding ACHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Acadia Healthcare Company Inc (NASDAQ:ACHC).
Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.